{
    "organizations": [],
    "uuid": "9fa275598d519ab4fc870166751eda8e4881bf93",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-qiagens-quantiferon-tb-gold-plus-g/brief-qiagens-quantiferon-tb-gold-plus-gains-approval-in-japan-idUSFWN1PY1L8",
    "ord_in_thread": 0,
    "title": "BRIEF-‍Qiagen's QuantiFERON-TB Gold Plus Gains Approval In Japan​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Qiagen Nv:\n* ‍QIAGEN‘S QUANTIFERON-TB GOLD PLUS GAINS APPROVAL IN JAPAN​\n* ‍JAPAN‘S MINISTRY OF HEALTH LABOR AND WELFARE HAS APPROVED QUANTIFERON(®)-TB GOLD PLUS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-09T05:31:00.000+02:00",
    "crawled": "2018-02-09T16:45:01.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "qiagen",
        "nv",
        "gold",
        "plus",
        "gain",
        "approval",
        "ministry",
        "health",
        "labor",
        "welfare",
        "approved",
        "quantiferon",
        "gold",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}